The quality of life in patients with Crohn's disease.

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87

Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci (2014) 1.41

Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg (2010) 1.41

Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33

Short pediatric Crohn's disease activity index for quality improvement and observational research. Inflamm Bowel Dis (2010) 1.16

Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease. Can J Gastroenterol (2009) 1.06

Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial. Can J Gastroenterol (2011) 1.03

Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr (2008) 1.02

Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation. Gut Microbes (2013) 0.97

The impact of co-existing immune-mediated on phenotype and outcomes in inflammatory bowel diseases. Aliment Pharmacol Ther (2017) 0.96

Crohn's disease: a patient's perspective. Int J Colorectal Dis (2007) 0.92

Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications. World J Gastroenterol (2013) 0.91

Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease. Int J Colorectal Dis (2007) 0.91

Comparison between handgrip strength, subjective global assessment, anthropometry, and biochemical markers in assessing nutritional status of patients with Crohn's disease in clinical remission. Dig Dis Sci (2009) 0.89

Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.89

Hematopoietic cell transplantation for Crohn's disease; is it time? World J Gastroenterol (2006) 0.87

Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners). J Am Med Inform Assoc (2016) 0.86

Health related quality of life in inflammatory bowel disease: the impact of surgical therapy. World J Gastroenterol (2010) 0.86

A new tool to measure the burden of Crohn's disease and its treatment: do patient and physician perceptions match? Inflamm Bowel Dis (2010) 0.85

Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire. Gut (2013) 0.83

Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey. J Gastroenterol (2016) 0.82

Treatment of pediatric refractory Crohn's disease with thalidomide. World J Gastroenterol (2011) 0.81

The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease. Neuropsychiatr Dis Treat (2016) 0.81

Optimizing management of Crohn's disease within a project management framework: results of a pilot study. Inflamm Bowel Dis (2011) 0.80

Progress in the diagnosis and treatment of inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2011) 0.79

Estimation of quality of life in Cypriot patients with inflammatory bowel disease. World J Gastroenterol (2017) 0.78

Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire. Clin Exp Gastroenterol (2011) 0.78

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial. JMIR Res Protoc (2015) 0.78

Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis (2010) 0.76

A phase II study of laquinimod in Crohn's disease. Gut (2014) 0.76

Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q(©)). Patient Prefer Adherence (2014) 0.75

Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications. Appl Health Econ Health Policy (2017) 0.75

Crohn's disease: Adalimumab improves quality of life. Nat Rev Gastroenterol Hepatol (2009) 0.75

Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol (2017) 0.75

Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases. Inflamm Bowel Dis (2017) 0.75